Influence
July 1, 2025

Shortening the Patient Health Questionnaire–9—When Brief Scales May Suffice

Kurt Kroenke, MD

Published in JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Kurt Kroenke, MD

A new depression screening tool, the Quick PHQ-3 (QP-3), has been developed as a streamlined version of the widely used 9-item Patient Health Questionnaire (PHQ-9). The QP-3 includes just three items—interest, depressed mood and self-esteem—and demonstrated 98% sensitivity and 76% specificity in identifying moderate or greater depression symptoms.

The tool was evaluated using data from over 96,000 respondents across all 50 U.S. states. The study employed advanced psychometric techniques and was conducted in four waves to ensure reliability across a demographically diverse population. The QP-3’s performance was found to be comparable to longer instruments such as the 4-item PHQ-Dep-4.

Although the QP-3 has not yet been validated against structured psychiatric interviews, its utility is promising in scenarios where brief assessments are necessary. These include mobile health applications, large-scale health screenings or research settings where depression is a secondary outcome.

The full PHQ-9 remains the preferred tool when comprehensive evaluation is required. It captures the full range of diagnostic criteria for major depressive disorder, tracks residual symptoms, includes a critical item on suicidal ideation and supports treatment decisions based on established severity cutoffs.

Additionally, a “gated” approach—using a single-item screener followed by the remaining items only when necessary—has shown potential to cut response burden by nearly half without compromising accuracy.

The availability of brief validated screeners like the QP-3 enhances options for mental health assessment across diverse settings and populations.

Authors:

Kurt Kroenke1,2

Affiliations

1Division of General Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis

2Regenstrief Institute Inc, Indianapolis, Indiana

Partners

Related News

Fairbanks, Lilly, Regenstrief and Indiana employers collaborate to study obesity medications’ impact

Fairbanks, Lilly, Regenstrief and Indiana employers collaborate to study obesity medications’ impact

INDIANAPOLIS — Researchers from the Fairbanks School of Public Health at Indiana University Indianapolis have launched a first-of-its-kind study

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults

Findings support longer-duration or targeted approaches A multi-center randomized controlled trial with critically ill adults aged 50 years and

Regenstrief experts lead, to present at 2nd biennial HEALeR symposium to explore ethics in learning health systems

The HEALeR Consortium will host its second biennial Symposium on November 6, 2025, at the NCAA Conference Center, 700

Regenstrief scientist elected to American College of Medical Informatics

Kun Huang, PhD, research scientist at the Clem McDonald Center for Biomedical Informatics at the Regenstrief Institute, has been